Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	mannosyl-oligosaccharide 1,2-alpha-mannosidase activity	MAN1A1 MAN1C1	2.38e-04	8	59	2	GO:0004571
GeneOntologyMolecularFunction	hydrolase activity, hydrolyzing O-glycosyl compounds	MAN1A1 MAN1C1 LYG2 SI	2.44e-04	103	59	4	GO:0004553
GeneOntologyMolecularFunction	mannosyl-oligosaccharide mannosidase activity	MAN1A1 MAN1C1	3.80e-04	10	59	2	GO:0015924
GeneOntologyMolecularFunction	hydrolase activity, acting on glycosyl bonds	MAN1A1 MAN1C1 LYG2 SI	8.68e-04	144	59	4	GO:0016798
GeneOntologyMolecularFunction	alpha-mannosidase activity	MAN1A1 MAN1C1	8.79e-04	15	59	2	GO:0004559
GeneOntologyMolecularFunction	carbonate dehydratase activity	CA2 CA5A	1.00e-03	16	59	2	GO:0004089
GeneOntologyMolecularFunction	mannosidase activity	MAN1A1 MAN1C1	1.00e-03	16	59	2	GO:0015923
GeneOntologyMolecularFunction	ubiquitin-like protein ligase activity	ZNF451 MIB1 RNF10 HERC2 RNF43 FBXO30	1.12e-03	398	59	6	GO:0061659
GeneOntologyBiologicalProcess	siRNA-mediated post-transcriptional gene silencing	AGO1 AGO3	5.14e-05	4	61	2	GO:0140766
GeneOntologyBiologicalProcess	siRNA-mediated gene silencing by mRNA destabilization	AGO1 AGO3	5.14e-05	4	61	2	GO:0090625
GeneOntologyBiologicalProcess	regulation of cell differentiation involved in phenotypic switching	SOD2 DNMT1	8.55e-05	5	61	2	GO:1905915
GeneOntologyBiologicalProcess	regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching	SOD2 DNMT1	8.55e-05	5	61	2	GO:1905930
GeneOntologyBiologicalProcess	vascular associated smooth muscle cell differentiation involved in phenotypic switching	SOD2 DNMT1	8.55e-05	5	61	2	GO:1905420
GeneOntologyBiologicalProcess	cell differentiation involved in phenotypic switching	SOD2 DNMT1	8.55e-05	5	61	2	GO:0090679
GeneOntologyBiologicalProcess	ubiquitin-dependent glycoprotein ERAD pathway	MAN1A1 MAN1C1	2.38e-04	8	61	2	GO:0097466
GeneOntologyBiologicalProcess	protein deglycosylation involved in glycoprotein catabolic process	MAN1A1 MAN1C1	2.38e-04	8	61	2	GO:0035977
GeneOntologyBiologicalProcess	protein alpha-1,2-demannosylation	MAN1A1 MAN1C1	2.38e-04	8	61	2	GO:0036508
GeneOntologyBiologicalProcess	protein demannosylation	MAN1A1 MAN1C1	2.38e-04	8	61	2	GO:0036507
GeneOntologyBiologicalProcess	mannose trimming involved in glycoprotein ERAD pathway	MAN1A1 MAN1C1	2.38e-04	8	61	2	GO:1904382
GeneOntologyBiologicalProcess	RNA secondary structure unwinding	AGO1 AGO3	3.06e-04	9	61	2	GO:0010501
GeneOntologyBiologicalProcess	RISC complex assembly	AGO1 AGO3	3.81e-04	10	61	2	GO:0070922
GeneOntologyBiologicalProcess	negative regulation of Notch signaling pathway	HEY1 HERC2 YTHDF2	3.87e-04	48	61	3	GO:0045746
GeneOntologyCellularComponent	P-body	AGO1 AGO3 TNRC6C YTHDF2	2.25e-04	102	61	4	GO:0000932
GeneOntologyCellularComponent	RISC-loading complex	AGO1 AGO3	3.71e-04	10	61	2	GO:0070578
GeneOntologyCellularComponent	cluster of actin-based cell projections	RALGDS LOXHD1 PAFAH1B1 SI PKHD1L1	4.83e-04	223	61	5	GO:0098862
Domain	ZZ	DTNB MIB1 HERC2	2.49e-05	18	60	3	PF00569
Domain	ZF_ZZ_2	DTNB MIB1 HERC2	2.49e-05	18	60	3	PS50135
Domain	ZF_ZZ_1	DTNB MIB1 HERC2	2.49e-05	18	60	3	PS01357
Domain	Znf_ZZ	DTNB MIB1 HERC2	2.94e-05	19	60	3	IPR000433
Domain	ZnF_ZZ	DTNB MIB1 HERC2	2.94e-05	19	60	3	SM00291
Domain	Argonaute_N	AGO1 AGO3	6.06e-05	4	60	2	IPR032474
Domain	Argonaute_Mid_dom	AGO1 AGO3	6.06e-05	4	60	2	IPR032473
Domain	ArgoL2	AGO1 AGO3	6.06e-05	4	60	2	IPR032472
Domain	Mib_Herc2	MIB1 HERC2	6.06e-05	4	60	2	IPR010606
Domain	MIB_HERC2	MIB1 HERC2	6.06e-05	4	60	2	PS51416
Domain	MIB_HERC2	MIB1 HERC2	6.06e-05	4	60	2	PF06701
Domain	ArgoN	AGO1 AGO3	6.06e-05	4	60	2	PF16486
Domain	ArgoMid	AGO1 AGO3	6.06e-05	4	60	2	PF16487
Domain	ArgoL2	AGO1 AGO3	6.06e-05	4	60	2	PF16488
Domain	DUF1785	AGO1 AGO3	1.01e-04	5	60	2	SM01163
Domain	ArgoL1	AGO1 AGO3	1.51e-04	6	60	2	PF08699
Domain	ArgoL1	AGO1 AGO3	1.51e-04	6	60	2	IPR014811
Domain	Glyco_hydro_47	MAN1A1 MAN1C1	2.11e-04	7	60	2	PF01532
Domain	-	MAN1A1 MAN1C1	2.11e-04	7	60	2	1.50.10.50
Domain	PIWI	AGO1 AGO3	2.81e-04	8	60	2	PS50822
Domain	Piwi	AGO1 AGO3	2.81e-04	8	60	2	SM00950
Domain	Piwi	AGO1 AGO3	2.81e-04	8	60	2	IPR003165
Domain	Piwi	AGO1 AGO3	2.81e-04	8	60	2	PF02171
Domain	Glyco_hydro_47	MAN1A1 MAN1C1	2.81e-04	8	60	2	IPR001382
Domain	PAZ	AGO1 AGO3	3.60e-04	9	60	2	PS50821
Domain	PAZ	AGO1 AGO3	3.60e-04	9	60	2	SM00949
Domain	PAZ_dom	AGO1 AGO3	3.60e-04	9	60	2	IPR003100
Domain	PAZ	AGO1 AGO3	3.60e-04	9	60	2	PF02170
Domain	Carbonic_anhydrase_a-class_CS	CA2 CA5A	6.56e-04	12	60	2	IPR018338
Domain	Carbonic_anhydrase_a-class	CA2 CA5A	1.04e-03	15	60	2	IPR023561
Domain	ALPHA_CA_1	CA2 CA5A	1.04e-03	15	60	2	PS00162
Domain	ALPHA_CA_2	CA2 CA5A	1.34e-03	17	60	2	PS51144
Domain	Carb_anhydrase	CA2 CA5A	1.34e-03	17	60	2	PF00194
Domain	Carb_anhydrase	CA2 CA5A	1.34e-03	17	60	2	SM01057
Domain	-	CA2 CA5A	1.34e-03	17	60	2	3.10.200.10
Domain	Carbonic_anhydrase_a	CA2 CA5A	1.34e-03	17	60	2	IPR001148
Domain	MAM	MALRD1 MAMDC4	1.34e-03	17	60	2	SM00137
Domain	MAM	MALRD1 MAMDC4	1.50e-03	18	60	2	PF00629
Domain	MAM_dom	MALRD1 MAMDC4	1.50e-03	18	60	2	IPR000998
Domain	MAM_2	MALRD1 MAMDC4	1.50e-03	18	60	2	PS50060
Domain	RCC1	RCCD1 HERC2	1.86e-03	20	60	2	PF00415
Domain	RCC1_1	RCCD1 HERC2	2.05e-03	21	60	2	PS00625
Domain	RCC1_2	RCCD1 HERC2	2.05e-03	21	60	2	PS00626
Domain	RCC1_3	RCCD1 HERC2	2.05e-03	21	60	2	PS50012
Domain	Reg_chr_condens	RCCD1 HERC2	2.25e-03	22	60	2	IPR000408
Domain	-	RCCD1 HERC2	2.25e-03	22	60	2	2.130.10.30
Domain	RCC1/BLIP-II	RCCD1 HERC2	2.46e-03	23	60	2	IPR009091
Pathway	REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS	AGO1 AGO3 TNRC6C	9.17e-07	7	43	3	M46421
Pathway	REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION	AGO1 AGO3 TNRC6C	2.19e-06	9	43	3	M27810
Pathway	REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION	AGO1 AGO3 TNRC6C	2.19e-06	9	43	3	M46436
Pathway	REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS	AGO1 AGO3 TNRC6C	3.13e-06	10	43	3	M48013
Pathway	REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER	AGO1 AGO3 TNRC6C DNMT1	3.67e-06	35	43	4	M42525
Pathway	REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION	AGO1 AGO3 TNRC6C	7.40e-06	13	43	3	M46434
Pathway	REACTOME_SIGNALING_BY_NOTCH	HDAC11 AGO1 AGO3 HEY1 MIB1 TNRC6C ATP2A1	8.53e-06	246	43	7	M10189
Pathway	REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY	AGO1 AGO3 TNRC6C	1.74e-05	17	43	3	M27788
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS	AGO1 AGO3 TNRC6C	2.48e-05	19	43	3	M48238
Pathway	REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS	HDAC11 AGO1 AGO3 HEY1 MIB1 TNRC6C RNF43 DNMT1	6.82e-05	464	43	8	M27547
Pathway	REACTOME_TGFBR3_EXPRESSION	AGO1 AGO3 TNRC6C	8.21e-05	28	43	3	M48253
Pathway	REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI	MAN1A1 MAN1C1	9.04e-05	5	43	2	M27954
Pathway	BIOCARTA_DICER_PATHWAY	AGO1 AGO3	9.04e-05	5	43	2	M22079
Pathway	REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI	MAN1A1 MAN1C1	9.04e-05	5	43	2	MM15670
Pathway	REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION	AGO1 AGO3 TNRC6C	1.23e-04	32	43	3	M48012
Pathway	REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY	AGO1 AGO3 TNRC6C	1.23e-04	32	43	3	M27900
Pathway	REACTOME_MICRORNA_MIRNA_BIOGENESIS	AGO1 AGO3	1.35e-04	6	43	2	MM14818
Pathway	REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS	AGO1 AGO3	1.35e-04	6	43	2	MM15083
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4	AGO1 AGO3 TNRC6C	1.48e-04	34	43	3	M46422
Pathway	REACTOME_ONCOGENE_INDUCED_SENESCENCE	AGO1 AGO3 TNRC6C	1.62e-04	35	43	3	M27190
Pathway	REACTOME_SIGNALING_BY_ALK_IN_CANCER	AGO1 AGO3 TNRC6C DNMT1	1.80e-04	93	43	4	M42521
Pathway	REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX	AGO1 AGO3 TNRC6C	1.91e-04	37	43	3	M29790
Pathway	REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS	AGO1 AGO3	2.52e-04	8	43	2	MM15082
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX	AGO1 AGO3 TNRC6C	2.60e-04	41	43	3	M29748
Pathway	REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS	AGO1 AGO3	3.23e-04	9	43	2	M27340
Pathway	REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING	AGO1 AGO3 TNRC6C	3.90e-04	47	43	3	M29777
Pathway	REACTOME_SIGNALING_BY_TGFBR3	AGO1 AGO3 TNRC6C	4.42e-04	49	43	3	M48250
Pathway	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	AGO1 AGO3 TNRC6C ATP2A1	4.62e-04	119	43	4	M607
Pathway	REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE	CA2 CA5A	5.88e-04	12	43	2	M671
Pathway	REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE	CA2 CA5A	5.88e-04	12	43	2	MM14574
Pathway	REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER	HDAC11 HEY1 MIB1	7.26e-04	58	43	3	M29616
Pathway	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	AGO1 AGO3 TNRC6C	7.26e-04	58	43	3	M11980
Pathway	WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION	AGO1 DGKA IKBKB	8.41e-04	61	43	3	M42548
Pathway	REACTOME_CA2_PATHWAY	AGO1 AGO3 TNRC6C	8.82e-04	62	43	3	M27321
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2	AGO1 AGO3 TNRC6C	9.24e-04	63	43	3	M27862
Pathway	BIOCARTA_AMAN_PATHWAY	MAN1A1 MAN1C1	9.31e-04	15	43	2	M22009
Pathway	REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING	FZD1 AGO1 AGO3 TNRC6C	9.96e-04	146	43	4	M27288
Pathway	KEGG_MEDICUS_REFERENCE_N_GLYCAN_BIOSYNTHESIS	MAN1A1 MAN1C1	1.06e-03	16	43	2	M47632
Pathway	REACTOME_SIGNALING_BY_NOTCH1	HDAC11 HEY1 MIB1	1.47e-03	74	43	3	M616
Pathway	KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO	FZD1 RNF43	1.50e-03	19	43	2	M47833
Pathway	BIOCARTA_ERAD_PATHWAY	MAN1A1 MAN1C1	1.50e-03	19	43	2	M22013
Pathway	WP_TYPE_II_DIABETES_MELLITUS	PHKA2 IKBKB	2.02e-03	22	43	2	M39658
Pathway	REACTOME_TP53_REGULATES_METABOLIC_GENES	AGO1 AGO3 TNRC6C	2.12e-03	84	43	3	M27495
Pathway	KEGG_NITROGEN_METABOLISM	CA2 CA5A	2.21e-03	23	43	2	M4629
Pathway	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	AGO1 AGO3 TNRC6C	2.58e-03	90	43	3	M820
Pathway	REACTOME_MICRORNA_MIRNA_BIOGENESIS	AGO1 AGO3	2.61e-03	25	43	2	M712
Pubmed	Functional dissection of the human TNRC6 (GW182-related) family of proteins.	AGO1 AGO3 TNRC6C	1.88e-07	7	62	3	19470757
Pubmed	The C-terminal domains of human TNRC6A, TNRC6B, and TNRC6C silence bound transcripts independently of Argonaute proteins.	AGO1 AGO3 TNRC6C	1.88e-07	7	62	3	19383768
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	AGO1 AGO3 TNRC6C HERC2 ATP2A1	2.56e-07	76	62	5	27542412
Pubmed	Enhanced susceptibility of Ago1/3 double-null mice to influenza A virus infection.	AGO1 AGO3	3.13e-06	2	62	2	22318144
Pubmed	Turning catalytically inactive human Argonaute proteins into active slicer enzymes.	AGO1 AGO3	9.37e-06	3	62	2	23665583
Pubmed	Characterization of a cDNA encoding a novel human Golgi alpha 1, 2-mannosidase (IC) involved in N-glycan biosynthesis.	MAN1A1 MAN1C1	9.37e-06	3	62	2	10915796
Pubmed	The roles of individual mammalian argonautes in RNA interference in vivo.	AGO1 AGO3	9.37e-06	3	62	2	24992693
Pubmed	Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex.	MAN1A1 MAN1C1	9.37e-06	3	62	2	2406237
Pubmed	Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family.	CA2 CA5A	9.37e-06	3	62	2	14600151
Pubmed	MiR-140-5p regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and differentiation by targeting Dnmt1 and promoting SOD2 expression.	SOD2 DNMT1	9.37e-06	3	62	2	27021683
Pubmed	Argonaute proteins in cardiac tissue contribute to the heart injury during viral myocarditis.	AGO1 AGO3	9.37e-06	3	62	2	26764146
Pubmed	Apoptosis-inducing factor regulates death in peripheral T cells.	TXNDC12 SOD2	9.37e-06	3	62	2	17617569
Pubmed	Argonaute2 is the catalytic engine of mammalian RNAi.	AGO1 AGO3	9.37e-06	3	62	2	15284456
Pubmed	Functional proteomics mapping of a human signaling pathway.	HIPK3 PHKA2 ZNF106 HEY1 MAN1C1 ZNF451 HERC2 INVS	1.00e-05	591	62	8	15231748
Pubmed	Stimulation of ERAD of misfolded null Hong Kong alpha1-antitrypsin by Golgi alpha1,2-mannosidases.	MAN1A1 MAN1C1	1.87e-05	4	62	2	17727818
Pubmed	Molecular dissection of human Argonaute proteins by DNA shuffling.	AGO1 AGO3	1.87e-05	4	62	2	23748378
Pubmed	Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.	AGO1 AGO3	1.87e-05	4	62	2	15260970
Pubmed	EHD1 promotes CP110 ubiquitination by centriolar satellite delivery of HERC2 to the mother centriole.	MIB1 HERC2	1.87e-05	4	62	2	37074924
Pubmed	Slicing-independent RISC activation requires the argonaute PAZ domain.	AGO1 AGO3	1.87e-05	4	62	2	22795694
Pubmed	ATP-dependent human RISC assembly pathways.	AGO1 AGO3	1.87e-05	4	62	2	19966796
Pubmed	Importance of translation and nonnucleolytic ago proteins for on-target RNA interference.	AGO1 AGO3	1.87e-05	4	62	2	18771919
Pubmed	A Requirement for Argonaute 4 in Mammalian Antiviral Defense.	AGO1 AGO3	1.87e-05	4	62	2	32049003
Pubmed	Short-interfering-RNA-mediated gene silencing in mammalian cells requires Dicer and eIF2C translation initiation factors.	AGO1 AGO3	3.12e-05	5	62	2	12526743
Pubmed	Differential expression of Dicer and Argonaute genes during the differentiation of human neuroblastoma cells.	AGO1 AGO3	3.12e-05	5	62	2	19393748
Pubmed	Suppression of long non-coding RNA TNRC6C-AS1 protects against thyroid carcinoma through DNA demethylation of STK4 via the Hippo signalling pathway.	TNRC6C DNMT1	3.12e-05	5	62	2	30938030
Pubmed	Differential expression of components of the microRNA machinery during mouse organogenesis.	AGO1 AGO3	3.12e-05	5	62	2	16036130
Pubmed	Quantitative functions of Argonaute proteins in mammalian development.	AGO1 AGO3	3.12e-05	5	62	2	22474261
Pubmed	The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis.	AGO1 AGO3	3.12e-05	5	62	2	12414724
Pubmed	The C-terminal half of human Ago2 binds to multiple GW-rich regions of GW182 and requires GW182 to mediate silencing.	AGO1 AGO3	3.12e-05	5	62	2	19324964
Pubmed	Hey1 and Hey2 are differently expressed during mouse tooth development.	HEY1 PAX9	3.12e-05	5	62	2	29155305
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	JPH1 PHKA2 ZNF106 ZNF451 PAFAH1B1 MIB1 ZNF324 HERC2 FBXO30 CA2	3.51e-05	1155	62	10	20360068
Pubmed	Linking functions: an additional role for an intrinsically disordered linker domain in the transcriptional coactivator CBP.	HIPK3 ZNF106 ZNF451	4.35e-05	38	62	3	28680062
Pubmed	Argonaute Utilization for miRNA Silencing Is Determined by Phosphorylation-Dependent Recruitment of LIM-Domain-Containing Proteins.	AGO1 AGO3	6.53e-05	7	62	2	28683311
Pubmed	Genome-wide identification of microRNA targets reveals positive regulation of the Hippo pathway by miR-122 during liver development.	AGO1 AGO3	6.53e-05	7	62	2	34907157
Pubmed	Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps.	AGO1 AGO3	6.53e-05	7	62	2	19536157
Pubmed	Respiratory distress and neonatal lethality in mice lacking Golgi alpha1,2-mannosidase IB involved in N-glycan maturation.	MAN1A1 MAN1C1	8.69e-05	8	62	2	17121831
Pubmed	ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress.	TXNDC12 SOD2	8.69e-05	8	62	2	24191052
Pubmed	MicroRNA-500 sustains nuclear factor-κB activation and induces gastric cancer cell proliferation and resistance to apoptosis.	AGO1 IKBKB	8.69e-05	8	62	2	25595906
Pubmed	Mili interacts with tudor domain-containing protein 1 in regulating spermatogenesis.	AGO1 AGO3	8.69e-05	8	62	2	19345100
Pubmed	Suppression of microRNA Activity in Kidney Collecting Ducts Induces Partial Loss of Epithelial Phenotype and Renal Fibrosis.	AGO1 AGO3	8.69e-05	8	62	2	29021386
Pubmed	Deterministic and stochastic allele specific gene expression in single mouse blastomeres.	FZD1 HDAC11 AGO1 AGO3 TXNDC12 DNMT1	1.09e-04	424	62	6	21731673
Pubmed	Identification of eight members of the Argonaute family in the human genome.	AGO1 AGO3	1.12e-04	9	62	2	12906857
Pubmed	Transcript profiling identifies dynamic gene expression patterns and an important role for Nrf2/Keap1 pathway in the developing mouse esophagus.	PAX9 SBSN	1.12e-04	9	62	2	22567161
Pubmed	Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis.	FZD1 HEY1	1.39e-04	10	62	2	17496152
Pubmed	HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies.	AGO1 AGO3	1.70e-04	11	62	2	22915799
Pubmed	Nudel binds Cdc42GAP to modulate Cdc42 activity at the leading edge of migrating cells.	TUBB1 PAFAH1B1	1.70e-04	11	62	2	18331715
Pubmed	A systematic quantification of carbonic anhydrase transcripts in the mouse digestive system.	CA2 CA5A	2.04e-04	12	62	2	17362527
Pubmed	A human MAP kinase interactome.	HIPK3 RALGDS ZNF106 ZNF451 HERC2 FBXO30	2.29e-04	486	62	6	20936779
Pubmed	Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation.	AGO1 TNRC6C	2.81e-04	14	62	2	19716330
Pubmed	Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection.	IKBKB ITGAL	2.81e-04	14	62	2	30131424
Pubmed	Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface.	MAN1A1 MAN1C1	3.23e-04	15	62	2	8892864
Pubmed	Microtubule-dependent apical polarization of basement membrane matrix mRNAs in mouse epithelial cells.	PAX9 TXNDC12	3.23e-04	15	62	2	38103869
Pubmed	Mind bomb1 is a ubiquitin ligase essential for mouse embryonic development and Notch signaling.	HEY1 MIB1	3.69e-04	16	62	2	16061358
Pubmed	Impaired placental trophoblast lineage differentiation in Alkbh1(-/-) mice.	GCM1 CA2	3.69e-04	16	62	2	18163532
Pubmed	Tooth morphogenesis and ameloblast differentiation are regulated by micro-RNAs.	AGO1 AGO3	3.69e-04	16	62	2	20102707
Pubmed	TRIM24 is an insulin-responsive regulator of P-bodies.	AGO1 AGO3 TNRC6C	4.02e-04	80	62	3	35803934
Pubmed	Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.	MAN1A1 MAN1C1	4.18e-04	17	62	2	2355006
Pubmed	The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.	DTNB HERC2	4.18e-04	17	62	2	23502783
Pubmed	Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex.	NFE2L3 PAFAH1B1 MIB1	4.32e-04	82	62	3	31073041
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	JPH1 NFE2L3 HEY1 ZNF451 MIB1 RNF10 HERC2 PREPL DNMT1	4.34e-04	1285	62	9	35914814
Pubmed	Low 8-oxo-7,8-dihydro-2'-deoxyguanosine levels and influence of genetic background in an Andean population exposed to high levels of arsenic.	SOD2 DNMT1	4.70e-04	18	62	2	19896490
Pubmed	Tbx1 and Foxi3 genetically interact in the pharyngeal pouch endoderm in a mouse model for 22q11.2 deletion syndrome.	HEY1 PAX9	4.70e-04	18	62	2	31412026
Pubmed	Altered feto-placental vascularization, feto-placental malperfusion and fetal growth restriction in mice with Egfl7 loss of function.	HEY1 GCM1	5.24e-04	19	62	2	28526753
Pubmed	SHARPIN negatively associates with TRAF2-mediated NFκB activation.	ZNF106 TXNDC12	5.24e-04	19	62	2	21829440
Pubmed	Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy.	HEY1 MIB1	5.82e-04	20	62	2	23314057
Pubmed	Mammalian Llgl2 is necessary for proper branching morphogenesis during placental development.	HEY1 GCM1	5.82e-04	20	62	2	21606200
Pubmed	Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin.	MAN1A1 MAN1C1	5.82e-04	20	62	2	12560567
Pubmed	Pax9 and Jagged1 act downstream of Gli3 in vertebrate limb development.	HEY1 PAX9	5.82e-04	20	62	2	16169709
Pubmed	An obligatory role of mind bomb-1 in notch signaling of mammalian development.	HEY1 MIB1	6.42e-04	21	62	2	18043734
Pubmed	Ephrin-B2 governs morphogenesis of endolymphatic sac and duct epithelia in the mouse inner ear.	HEY1 CA2	6.42e-04	21	62	2	24583262
Pubmed	Inactivation of Notch signaling in the renal collecting duct causes nephrogenic diabetes insipidus in mice.	MIB1 CA2	6.42e-04	21	62	2	19855135
Pubmed	Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response.	MAN1A1 MAN1C1	7.06e-04	22	62	2	8673525
Pubmed	Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation.	MAN1A1 MAN1C1	7.06e-04	22	62	2	9109416
Pubmed	Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum.	MAN1A1 MAN1C1	7.06e-04	22	62	2	11530211
Pubmed	A systematic survey of carbonic anhydrase mRNA expression during mammalian inner ear development.	CA2 CA5A	7.06e-04	22	62	2	23233153
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FZD1 TNRC6C HERC2 MRPL46 ZNF865 RNF43 TIAM2 TJP3	7.49e-04	1105	62	8	35748872
Pubmed	Role of asparagine-linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function.	MAN1A1 MAN1C1	7.72e-04	23	62	2	1736542
Pubmed	Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.	MAN1A1 MAN1C1	7.72e-04	23	62	2	8093218
Pubmed	Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins.	MAN1A1 MAN1C1	7.72e-04	23	62	2	3099781
Pubmed	Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1.	MAN1A1 MAN1C1	7.72e-04	23	62	2	3264072
Pubmed	The DNA sequence and analysis of human chromosome 6.	TRERF1 MAN1A1 ZNF451 GCM1 FBXO30 SOD2	8.40e-04	622	62	6	14574404
Pubmed	Rhox8 homeobox gene ablation leads to rete testis abnormality and male subfertility in mice†.	HEY1 CA2	8.41e-04	24	62	2	37471646
Pubmed	Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins.	MAN1A1 MAN1C1	9.14e-04	25	62	2	2283726
Pubmed	Human transcription factor protein interaction networks.	TRERF1 AGO1 AGO3 ZNF451 GCM1 TNRC6C PAX9 HERC2 YTHDF2	9.27e-04	1429	62	9	35140242
Pubmed	A dual role for Ikk alpha in tooth development.	PAX9 IKBKB	9.89e-04	26	62	2	14960276
Pubmed	Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system.	MAN1A1 MAN1C1	9.89e-04	26	62	2	8218172
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	HIPK3 PHKA2 AGO1 AGO3 DTNB IKBKB YTHDF2	1.16e-03	910	62	7	36736316
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	JPH1 MIB1 PREPL SBSN TXNDC12 TIAM2 CA2	1.20e-03	916	62	7	32203420
Pubmed	TNIP1 inhibits selective autophagy via bipartite interaction with LC3/GABARAP and TAX1BP1.	MIB1 SBSN CA2	1.21e-03	117	62	3	36898370
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ZNF106 MAN1A1 ZNF451 PAFAH1B1 SBSN TXNDC12 CA2 SOD2	1.29e-03	1203	62	8	29180619
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	HDAC11 AGO1 AGO3 MIB1 YTHDF2	1.41e-03	462	62	5	31138677
Pubmed	The NXSM recombinant inbred strains of mice: genetic profile for 58 loci including the Mtv proviral loci.	ITGAL CA2	1.41e-03	31	62	2	2165966
Pubmed	A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.	ZNF106 ZNF324 DNMT1	1.47e-03	125	62	3	21654808
Pubmed	Mind bomb 1 is essential for generating functional Notch ligands to activate Notch.	HEY1 MIB1	1.59e-03	33	62	2	16000382
Pubmed	Lis1 mediates planar polarity of auditory hair cells through regulation of microtubule organization.	TUBB1 PAFAH1B1	1.69e-03	34	62	2	23533177
Interaction	CNOT6L interactions	GPBP1L1 AGO1 AGO3 MIB1 TNRC6C YTHDF2	4.10e-07	93	62	6	int:CNOT6L
Interaction	ATOH1 interactions	AGO1 AGO3 TNRC6C HERC2 ATP2A1	4.71e-06	80	62	5	int:ATOH1
Interaction	CPEB4 interactions	GPBP1L1 AGO1 AGO3 TNRC6C RNF43 YTHDF2	8.40e-06	156	62	6	int:CPEB4
Interaction	MKRN2 interactions	FZD1 AGO1 AGO3 MIB1 TNRC6C FITM2 RNF43 YTHDF2	2.27e-05	385	62	8	int:MKRN2
Interaction	TNRC6A interactions	GPBP1L1 AGO1 AGO3 MIB1 TNRC6C RNF43 YTHDF2	2.37e-05	280	62	7	int:TNRC6A
Interaction	TNRC6B interactions	GPBP1L1 AGO1 AGO3 MIB1 TNRC6C RNF43 YTHDF2	2.48e-05	282	62	7	int:TNRC6B
Interaction	FUBP3 interactions	AGO1 AGO3 TNRC6C PAX9 IKBKB RNF43 YTHDF2	3.46e-05	297	62	7	int:FUBP3
Interaction	TNRC6C interactions	GPBP1L1 AGO1 AGO3 TNRC6C YTHDF2	6.62e-05	138	62	5	int:TNRC6C
Interaction	CNOT7 interactions	GPBP1L1 AGO1 AGO3 TNRC6C YTHDF2	7.09e-05	140	62	5	int:CNOT7
Interaction	CNOT9 interactions	GPBP1L1 AGO1 AGO3 TNRC6C FITM2 YTHDF2	7.64e-05	231	62	6	int:CNOT9
Interaction	CTIF interactions	AGO1 AGO3 TNRC6C YTHDF2	9.29e-05	77	62	4	int:CTIF
Interaction	HELZ interactions	AGO1 AGO3 TNRC6C ANGPTL7 RNF43 YTHDF2	1.37e-04	257	62	6	int:HELZ
Interaction	DCP1A interactions	AGO1 AGO3 RCCD1 TNRC6C YTHDF2	1.58e-04	166	62	5	int:DCP1A
Interaction	GARRE1 interactions	GPBP1L1 AGO1 AGO3 TNRC6C YTHDF2	1.63e-04	167	62	5	int:GARRE1
Cytoband	8q21	JPH1 HEY1	1.17e-04	12	62	2	8q21
Cytoband	1p35	MAN1C1 YTHDF2	1.39e-04	13	62	2	1p35
Cytoband	19q13.42	SSC5D KIR3DX1 ZNF865	6.63e-04	125	62	3	19q13.42
Cytoband	6p12.1	ZNF451 GCM1	9.22e-04	33	62	2	6p12.1
Cytoband	Ensembl 112 genes in cytogenetic band chr6q25	ULBP1 TIAM2 SOD2	1.45e-03	164	62	3	chr6q25
Cytoband	Ensembl 112 genes in cytogenetic band chr8q21	JPH1 HEY1 CA2	2.27e-03	192	62	3	chr8q21
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	DTNB MIB1 HERC2	9.97e-06	18	43	3	91
GeneFamily	Mannosidases alpha class 1	MAN1A1 MAN1C1	3.31e-05	4	43	2	1193
GeneFamily	Argonaute/PIWI family	AGO1 AGO3	1.53e-04	8	43	2	408
GeneFamily	Carbonic anhydrases	CA2 CA5A	8.25e-04	18	43	2	460
Coexpression	GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP	TRERF1 ZNF106 AGO1 CLEC10A FITM2 PREPL	7.24e-06	197	62	6	M3343
ToppCell	droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFE2L3 MAN1C1 CLEC10A ATP2A1 ANGPTL7	3.84e-06	169	62	5	7962165cab84af73d20b56eb70b1ed87c94025ef
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NFE2L3 RCCD1 PKHD1L1 ANGPTL7 SBSN	4.30e-06	173	62	5	ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NFE2L3 RCCD1 PKHD1L1 ANGPTL7 SBSN	4.30e-06	173	62	5	3725525b99a6011eda2ff5459b4fd2e1eab1f090
ToppCell	droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFE2L3 MAN1C1 CLEC10A ATP2A1 ANGPTL7	4.55e-06	175	62	5	21bc0e59a9509d38751ce6aad2325f341bc70eff
ToppCell	droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFE2L3 MAN1C1 CLEC10A ATP2A1 ANGPTL7	5.08e-06	179	62	5	d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159
ToppCell	facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFE2L3 MAN1C1 CLEC10A ATP2A1 ANGPTL7	5.22e-06	180	62	5	bf8d13d4db1af55b8c9fe16aaccf8743e000e005
ToppCell	facs-Marrow-B-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFE2L3 MAN1C1 CLEC10A ATP2A1 ANGPTL7	5.22e-06	180	62	5	839defb40f7cfb2711e9025194de636533f51bcd
ToppCell	facs-Marrow-B-cells-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFE2L3 MAN1C1 CLEC10A ATP2A1 ANGPTL7	5.22e-06	180	62	5	82965ed1b72a1873c24dd4553d39681596057316
ToppCell	facs-Marrow-T-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAN1C1 CLEC10A IKBKB ITGAL ATP2A1	5.36e-06	181	62	5	7286700396676fdc41d9723979b8b408177aceb9
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TUBB1 MAN1A1 ZNF451 FBXO30 CA2	7.32e-06	193	62	5	305e15ee467826ee08b2617c69f250ad39c11b19
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TUBB1 MAN1A1 ZNF451 FBXO30 CA2	7.32e-06	193	62	5	dd376664906caccc9c2065f8e7a364509e18a5cc
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	KIR3DX1 ITGAL CA5A	5.56e-05	53	62	3	2147787ed3de18b49f51a8518984c7b6ba9a8cef
ToppCell	Fetal_29-31_weeks-Immune-mast_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TUBB1 NFE2L3 LINC00299 ANGPTL7	6.97e-05	158	62	4	0c27c475289c70b17b6a66fc71f628511c5f0ae1
ToppCell	severe_influenza-CD8+_T_naive\|World / disease group, cell group and cell class (v2)	RCCD1 MAN1C1 LYG2 INVS	7.32e-05	160	62	4	a1181ef36b453eba53b04d836aa9f65a71354cdb
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NFE2L3 PKHD1L1 ANGPTL7 SBSN	8.44e-05	166	62	4	545f6c91102568791443717e522f89cb3bd1a070
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NFE2L3 PKHD1L1 ANGPTL7 SBSN	8.64e-05	167	62	4	7abc785e688a384672d7fb5a62d32538fe7e5a51
ToppCell	P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	JPH1 DTNB RNF43 FBXO30	8.64e-05	167	62	4	5c3d0763f73628c71c71f9883556bb4f1639f3cc
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NFE2L3 PKHD1L1 ANGPTL7 SBSN	8.64e-05	167	62	4	d50311b1f66f143bae4c4cf50e2e9b13c85d6920
ToppCell	Adult-Immune-natural_killer_cell-D122\|Adult / Lineage, Cell type, age group and donor	TRERF1 KIR3DX1 LINC00299 ITGAL	8.64e-05	167	62	4	ff1ce3b1a2d91d2ad979f25899db4f4eeb865892
ToppCell	droplet-Lung-LUNG-30m-Myeloid-plasmacytoid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFE2L3 CLEC10A ATP2A1 ANGPTL7	8.84e-05	168	62	4	e156297a7515e785a9e79a9676700bd3a9d92b98
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Plasmacytoid_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFE2L3 CLEC10A ATP2A1 ANGPTL7	8.84e-05	168	62	4	32e0bc0873baa13027241063283ef26d2aab56f5
ToppCell	droplet-Lung-nan-18m-Myeloid-Plasmacytoid_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC10A ATP2A1 ANGPTL7 TJP3	9.25e-05	170	62	4	749144a1a869a6bf9acdd227184319083367dc3f
ToppCell	droplet-Lung-nan-18m-Myeloid-plasmacytoid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC10A ATP2A1 ANGPTL7 TJP3	9.25e-05	170	62	4	25d60a62e8f99c31ab64fe6a0c07ccca3df1a7ee
ToppCell	droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLEC10A ATP2A1 ANGPTL7 TJP3	9.68e-05	172	62	4	422d311bba2dd5d8bece4e96ee8c86e78086b62d
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NFE2L3 PKHD1L1 ANGPTL7 SBSN	9.68e-05	172	62	4	9a256db817c1af1802203cc88a55d608fb328c63
ToppCell	droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLEC10A ATP2A1 ANGPTL7 TJP3	9.68e-05	172	62	4	1abb6fbb28c8aff384540493d0f70eeacaa751f4
ToppCell	droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NFE2L3 CLEC10A ATP2A1 ANGPTL7	9.90e-05	173	62	4	4f0c065e876197ad8cae7856669f09e37ecafa3f
ToppCell	droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NFE2L3 CLEC10A ATP2A1 ANGPTL7	9.90e-05	173	62	4	9bbea566964281f47bf75d665b7d69ba8326e207
ToppCell	COVID-19-lung-RBC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TUBB1 ZNF451 PKHD1L1 CA2	1.03e-04	175	62	4	4c35292ad2ac712ba7516f27dd6eac6ba8fdd163
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NFE2L3 ZNF106 ZNF451 RNF43	1.03e-04	175	62	4	334fad1a147de6c007cec5089c02c35cf3220f1b
ToppCell	droplet-Spleen-SPLEEN-1m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAN1C1 CLEC10A ATP2A1 ANGPTL7	1.10e-04	178	62	4	742ee0cb8cb585a5e34bd5b20aebe9bb99756e0c
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFE2L3 CLEC10A ATP2A1 ANGPTL7	1.13e-04	179	62	4	1757b9f3f4c634277a67c4f5a39d27d6b4937073
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFE2L3 CLEC10A ATP2A1 ANGPTL7	1.15e-04	180	62	4	64f01494a4052186773720e10b4e7c724ff94547
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NFE2L3 PKHD1L1 ANGPTL7 SBSN	1.15e-04	180	62	4	2ccc77d769d3ffd77ab3af45e4f192785b6db79c
ToppCell	COVID-19-kidney-NK\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TRERF1 KIR3DX1 LINC00299 ITGAL	1.18e-04	181	62	4	8906ee8a7a1616dfe8c3b5c73988416641213629
ToppCell	MS\|World / Condition, Cell_class and T cell subcluster	LYG2 PKHD1L1 CA5A TJP3	1.18e-04	181	62	4	99f054a586a95947528dc3fd8043c1bda5e74cc4
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUBB1 LRFN4 FBXO30 CA2	1.18e-04	181	62	4	9dc0563453e24c9d1d975e2e0e1e272487e19908
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUBB1 LRFN4 FBXO30 CA2	1.18e-04	181	62	4	14c2dd946e89ba578711c2d25935b6b3d319b701
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUBB1 LRFN4 FBXO30 CA2	1.18e-04	181	62	4	c5843b89f3d362e236ff76c3279518a2fdfc1f75
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAN1A1 DTNB MAN1C1 CA2	1.18e-04	181	62	4	b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUBB1 LRFN4 FBXO30 CA2	1.18e-04	181	62	4	fcefb5902416c004631f4f8dd5c8f99fe3bd90bc
ToppCell	Adult-Immune-natural_killer_cell-D231\|Adult / Lineage, Cell type, age group and donor	TRERF1 KIR3DX1 LINC00299 ITGAL	1.20e-04	182	62	4	dbf47bf4754d8ec3bc3ab1d5be7a6c47a7afbf43
ToppCell	control-Others-Megakaryocytes\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TUBB1 PKHD1L1 CA2 SOD2	1.25e-04	184	62	4	213915f2889ce8ecbe5f7b19bc2b24ed8c5efe1d
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FZD1 SSC5D LRFN4 MAN1C1	1.25e-04	184	62	4	f6148e9591e8845cc62668e49fd52755257cdc7e
ToppCell	droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFE2L3 CLEC10A ATP2A1 ANGPTL7	1.28e-04	185	62	4	65dcb0a7ee64990a34a87c167b44497107f035ee
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAN1A1 DTNB MAN1C1 CA2	1.36e-04	188	62	4	58ccb31cdf43167872ef0fc737e6f9c51ee2e060
ToppCell	IPF-Lymphoid-NK\|IPF / Disease state, Lineage and Cell class	TRERF1 KIR3DX1 LINC00299 ITGAL	1.39e-04	189	62	4	d92e880162450f8d01e4b8784eb625275cb8e03e
ToppCell	Control-T_cells-CD4+_T_cells\|Control / group, cell type (main and fine annotations)	TRERF1 DGKA LINC00299 ITGAL	1.42e-04	190	62	4	0733be5e54fe15d6d6ea51c154a95258e83f1b92
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 DGKA LINC00299 ITGAL	1.42e-04	190	62	4	b772a5d281fe016f259ddda80d6f33d949dcac2b
ToppCell	Adult-Immune-natural_killer_cell\|Adult / Lineage, Cell type, age group and donor	TRERF1 KIR3DX1 LINC00299 ITGAL	1.45e-04	191	62	4	758ec27e47d7662a5175305e98a1506c6859dbf7
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRERF1 KIR3DX1 LINC00299 ITGAL	1.45e-04	191	62	4	9b8b64a36e27a2523b8730c7922fd7ad865a021e
ToppCell	IPF-Lymphoid-NK\|World / Disease state, Lineage and Cell class	TRERF1 KIR3DX1 LINC00299 ITGAL	1.45e-04	191	62	4	f206159b9d5e84cf14a65bfdc008895cec5a8081
ToppCell	Influenza_Severe-RBC\|Influenza_Severe / Disease group and Cell class	ZNF451 RNF10 FBXO30 CA2	1.48e-04	192	62	4	f19b6da3fd98da1a76d2570137a8f73a3850ebcb
ToppCell	Adult-Immune-T_lymphocyte\|Adult / Lineage, Cell type, age group and donor	TRERF1 DGKA LINC00299 ITGAL	1.51e-04	193	62	4	26df0c4c8a2355dd5503fadd07e368eb9a2bf06a
ToppCell	wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ZNF451 RNF10 ACKR2 FBXO30	1.51e-04	193	62	4	be75abfdf5301cf33df8ee9ed92504d44fdf19a6
ToppCell	severe_influenza-RBC\|severe_influenza / disease group, cell group and cell class (v2)	ZNF451 RNF10 FBXO30 CA2	1.51e-04	193	62	4	ffb0b3c2cce13b6891157f0fede2600f3938670e
ToppCell	COVID-19-lung-NK/NKT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TRERF1 KIR3DX1 LINC00299 ITGAL	1.51e-04	193	62	4	c24b44fcc92fff42ebba6f1aff91c7aaea179e56
ToppCell	Adult-Immune-T_lymphocyte-D231\|Adult / Lineage, Cell type, age group and donor	TRERF1 DGKA LINC00299 ITGAL	1.54e-04	194	62	4	5c1dca33f382f37a7deb23e573578343c3b54986
ToppCell	COVID-19-lung-NK_cells\|lung / Disease (COVID-19 only), tissue and cell type	TRERF1 KIR3DX1 LINC00299 ITGAL	1.57e-04	195	62	4	3b716ec7acc9a37af6bf40e711a539ce58d74aa4
ToppCell	COVID-19-lung-NK/NKT\|lung / Disease (COVID-19 only), tissue and cell type	TRERF1 KIR3DX1 LINC00299 ITGAL	1.57e-04	195	62	4	3ab941a369e3815f338890b116dc77aefa054098
ToppCell	wk_08-11-Hematologic-Myeloid-Myelocyte-like\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	HIPK3 AGO1 RCCD1 DGKA	1.60e-04	196	62	4	4b88c96b737a747422674ad99c073b28e6febc7c
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LYG2 DGKA LINC00299 TNRC6C	1.63e-04	197	62	4	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|Control_saline / Treatment groups by lineage, cell group, cell type	HDAC11 RNF10 PKHD1L1 FBXO30	1.66e-04	198	62	4	dd80fd9671ee863aebcf4c1023d3e004cc2ee709
ToppCell	T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	RALGDS DGKA TNRC6C ITGAL	1.66e-04	198	62	4	1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	HDAC11 PKHD1L1 FBXO30 CA2	1.69e-04	199	62	4	565404c155dfac57c020a8f2d09cbf756da20ffd
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRERF1 DGKA LINC00299 ITGAL	1.69e-04	199	62	4	fbdde57dd88656621801e65ee2818251588f3874
ToppCell	Influenza-Influenza_Severe-Others-RBC\|Influenza_Severe / Disease, condition lineage and cell class	ZNF451 RNF10 FBXO30 CA2	1.69e-04	199	62	4	da0fec0a492bc3827d9066d2590bcd466cd45564
ToppCell	(2)_Fibroblasts-(24)_Fibro-5\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	SSC5D ACKR2 ANGPTL7 SBSN	1.69e-04	199	62	4	6c0354f57883330c685a8d9d5d3014ace7eca584
Computational	Pol II transcription.	PHKA2 MIB1 HERC2 DNMT1	1.47e-04	71	41	4	MODULE_308
Drug	I7C	CA2 CA5A	2.18e-05	3	62	2	CID000069561
Drug	4-hydroxymethylbenzenesulfonamide	CA2 CA5A	2.18e-05	3	62	2	CID010081162
Drug	4-(2-aminopyrimidin-4-yl-amino)-benzenesulfonamide	CA2 CA5A	2.18e-05	3	62	2	CID000031035
Drug	AC1Q551A	CA2 CA5A	2.18e-05	3	62	2	CID011206245
Drug	AC1NA7ER	CA2 CA5A	2.18e-05	3	62	2	CID004422372
Drug	4-(2-aminoethyl)benzenesulfonamide	CA2 CA5A	2.18e-05	3	62	2	CID000169682
Drug	6-hydroxy-1,3-benzothiazole-2-sulfonamide	CA2 CA5A	2.18e-05	3	62	2	CID006852129
Drug	4-hydrazinobenzenesulfonamide	CA2 CA5A	2.18e-05	3	62	2	CID000078105
Drug	CTK1B7592	CA2 CA5A	2.18e-05	3	62	2	CID009998322
Drug	4-(2-hydroxyethyl)benzenesulfonamide	CA2 CA5A	2.18e-05	3	62	2	CID010375558
Drug	AC1NQARZ	CA2 CA5A	2.18e-05	3	62	2	CID005172475
Drug	sulpiride (SLP	CA2 CA5A	2.18e-05	3	62	2	CID003018597
Drug	1-alpha-25-dihydroxycholecalciferol	FZD1 HDAC11 MIB1 GCM1 PAX9 ITGAL ATP2A1 RNF43 CA2 SOD2 CA5A	3.04e-05	909	62	11	CID000002524
Drug	perchlorate	ATP2A1 CA2 SOD2 DNMT1 CA5A	3.12e-05	133	62	5	ctd:C494474
Drug	3-Iodosulfanilamide	CA2 CA5A	4.36e-05	4	62	2	CID009861037
Drug	NSC-700707	CA2 CA5A	4.36e-05	4	62	2	CID000134560
Drug	3-bromosulfanilamide	CA2 CA5A	4.36e-05	4	62	2	CID003526523
Drug	I-7B	CA2 CA5A	4.36e-05	4	62	2	CID000067136
Drug	AC1Q511M	CA2 CA5A	4.36e-05	4	62	2	CID004687472
Drug	PB311	CA2 CA5A	4.36e-05	4	62	2	CID001502014
Drug	potassium periodate	CA2 CA5A	7.26e-05	5	62	2	ctd:C037192
Drug	sodium metasilicate	CA2 CA5A	7.26e-05	5	62	2	ctd:C025349
Drug	Iodates	CA2 CA5A	7.26e-05	5	62	2	ctd:D007452
Drug	4-carbethoxyhexafluorobutyryl chloride	ACKR2 XPNPEP2	7.26e-05	5	62	2	CID000161251
Drug	cobalt-60	TUBB1 DTNB XPNPEP2 PREPL CA2 SOD2 CA5A	8.97e-05	390	62	7	CID000061492
Drug	AC1L9R2Z	HIPK3 TUBB1 HDAC11 HERC2 SOD2	9.49e-05	168	62	5	CID000453624
Drug	EMD 486019	CA2 CA5A	1.09e-04	6	62	2	CID011245700
Drug	orthanilamide	CA2 CA5A	1.09e-04	6	62	2	CID000072894
Drug	2h15	CA2 CA5A	1.09e-04	6	62	2	CID010712038
Drug	MG-262; Down 200; 0.1uM; MCF7; HT_HG-U133A	FZD1 LRFN4 MAN1A1 ZNF324 CA2	1.18e-04	176	62	5	7063_DN
Drug	gramicidin s	DTNB ATP2A1 SOD2	1.40e-04	37	62	3	CID000073357
Drug	chloric acid	CA2 CA5A	1.52e-04	7	62	2	ctd:C022842
Drug	Baralyme	HEY1 SOD2	1.52e-04	7	62	2	CID000170176
Drug	Carbonates	CA2 CA5A	1.52e-04	7	62	2	ctd:D002254
Drug	sulfamic acid	CA2 CA5A	1.52e-04	7	62	2	ctd:C005741
Drug	Nitric Acid	CA2 CA5A	1.52e-04	7	62	2	ctd:D017942
Drug	ethoxzolamide	SI CA2 CA5A	1.77e-04	40	62	3	CID000003295
Drug	ICI 182,780; Down 200; 1uM; MCF7; HG-U133A	FZD1 HIPK3 PHKA2 RALGDS MAN1A1	1.77e-04	192	62	5	367_DN
Drug	Spiramycin [8025-81-8]; Up 200; 4.8uM; PC3; HT_HG-U133A	HIPK3 HDAC11 MAN1A1 DGKA PAX9	1.95e-04	196	62	5	4319_UP
Drug	Azathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A	FZD1 PHKA2 MAN1A1 AGO3 ZNF324	1.95e-04	196	62	5	2827_DN
Drug	Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A	FZD1 ZNF324 IKBKB RNF43 TJP3	1.95e-04	196	62	5	2751_DN
Drug	Ribavirin [36791-04-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A	HIPK3 TUBB1 ZNF324 PAX9 ITGAL	1.95e-04	196	62	5	6018_UP
Drug	ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A	HDAC11 MAN1C1 ZNF324 IKBKB RNF43	1.95e-04	196	62	5	7091_UP
Drug	Meropenem [96036-03-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A	FZD1 MAN1A1 ZNF324 SOD2 TJP3	2.00e-04	197	62	5	7180_UP
Drug	Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A	HIPK3 RALGDS MAN1A1 PAFAH1B1 IKBKB	2.00e-04	197	62	5	4337_DN
Drug	lixazinone	ZNF106 MIB1	2.02e-04	8	62	2	CID000058573
Drug	Bromates	CA2 CA5A	2.02e-04	8	62	2	ctd:D001959
Drug	aminozolamide	CA2 CA5A	2.02e-04	8	62	2	CID000093505
Drug	L-662,583	CA2 CA5A	2.02e-04	8	62	2	CID003082977
Drug	L-643,799	CA2 CA5A	2.02e-04	8	62	2	CID000121595
Drug	sezolamide	CA2 CA5A	2.02e-04	8	62	2	CID000060692
Drug	Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; PC3; HT_HG-U133A	RALGDS DTNB ULBP1 ACKR2 TJP3	2.05e-04	198	62	5	5746_UP
Drug	SB 202190; Down 200; 1uM; PC3; HT_HG-U133A	FZD1 PAFAH1B1 PAX9 RNF43 SOD2	2.10e-04	199	62	5	6882_DN
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; MCF7; HT_HG-U133A	FZD1 HIPK3 MAN1C1 DGKA ULBP1	2.10e-04	199	62	5	5436_UP
Drug	Ifenprodil tartrate [23210-58-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A	HIPK3 ACKR2 PAX9 IKBKB RNF43	2.14e-04	200	62	5	7404_UP
Drug	Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	DTNB ZNF324 ULBP1 ACKR2 ATP2A1	2.14e-04	200	62	5	3840_UP
Drug	Chlorpyrifos	FZD1 ZNF106 DTNB PAFAH1B1 GCM1 PAX9 YTHDF2 FBXO30 CA2 SOD2	2.48e-04	960	62	10	ctd:D004390
Drug	tetrahydropyran	GPBP1L1 ACKR2 SOD2	2.51e-04	45	62	3	CID000008894
Drug	Pyrones	IKBKB SOD2	2.59e-04	9	62	2	ctd:D011753
Drug	qassa	CA2 CA5A	2.59e-04	9	62	2	CID003082191
Drug	6-hydroxyethoxzolamide	CA2 CA5A	2.59e-04	9	62	2	CID000094706
Drug	Febuxostat	IKBKB SOD2	2.59e-04	9	62	2	ctd:D000069465
Drug	zinc methionine	SI SOD2	2.59e-04	9	62	2	CID000162430
Disease	Pancreatic carcinoma	RNF43 SOD2	7.03e-04	19	61	2	C0235974
Disease	Breast Carcinoma	TRERF1 HEY1 RCCD1 HERC2 SOD2 DNMT1	8.49e-04	538	61	6	C0678222
Disease	Carcinoma, Pancreatic Ductal	HEY1 DNMT1	1.13e-03	24	61	2	C0887833
Disease	Malignant neoplasm of breast	TRERF1 HEY1 RCCD1 HERC2 IKBKB MAMDC4 SOD2 DNMT1	1.60e-03	1074	61	8	C0006142
Disease	Carcinoma, Granular Cell	CA2 SOD2 DNMT1	1.80e-03	116	61	3	C0205644
Disease	Adenocarcinoma, Tubular	CA2 SOD2 DNMT1	1.80e-03	116	61	3	C0205645
Disease	Adenocarcinoma, Oxyphilic	CA2 SOD2 DNMT1	1.80e-03	116	61	3	C0205642
Disease	Carcinoma, Cribriform	CA2 SOD2 DNMT1	1.80e-03	116	61	3	C0205643
Disease	Adenocarcinoma, Basal Cell	CA2 SOD2 DNMT1	1.80e-03	116	61	3	C0205641
Disease	Adenocarcinoma	CA2 SOD2 DNMT1	1.80e-03	116	61	3	C0001418

Protein segments in the cluster

Peptide	Gene	Start	Entry
GVWNCHADFGGHGTI	ACKR2	191	O00590
KDGNSLHRHGDQAWG	LINC00299	51	Q6ZSB3
AQGQLAVWGAGGHRR	MAMDC4	1076	Q6UXC1
PHTGNRHNHWAGLYG	DNMT1	1501	P26358
RGWAINVGGGFHHCS	HDAC11	131	Q96DB2
GGGREVWFGFHQSVR	AGO1	191	Q9UL18
HPLGGGREVWFGFHQ	AGO3	191	Q9H9G7
IGHFNDPVHGGSWFR	ATP2A1	276	O14983
SWGGGRHGQLGHGTL	RCCD1	181	A6NED2
GHDNWVRGVLFHSGG	PAFAH1B1	336	P43034
GSIRGDFWLGNEHIH	ANGPTL7	196	O43827
YVAGHGWQHAGGTSL	PAX9	296	P55771
LGTGGFGNVIRWHNQ	IKBKB	21	O14920
MSQRSGGGTGNHRHW	GPBP1L1	106	Q9HC44
GGGTGNHRHWNGSFH	GPBP1L1	111	Q9HC44
SGTIYGWGHNHRGQL	HERC2	3951	O95714
GWGHNHRGQLGGIEG	HERC2	3956	O95714
GQWAGGMRHGYGVRQ	JPH1	131	Q9HDC5
VSVGHGNVGVNRGWF	LOXHD1	361	Q8IVV2
PFSASGGWGRAGHLH	NFE2L3	61	Q9Y4A8
HGGSNLWGDTRRPHG	DGKA	606	P23743
FGSGHQEWNGNFGHR	HIPK3	1061	Q9H422
FRHGVAHGQWLSGGQ	KIR3DX1	256	Q9H7L2
AHGQWLSGGQRHREA	KIR3DX1	261	Q9H7L2
VQSLQHGHGGWTDGM	MIB1	261	Q86YT6
RWGLGNGISIHHGEE	MALRD1	1116	Q5VYJ5
LKQFHFHWGAVNEGG	CA5A	126	P35218
FWTSNPQHGGGGHRG	FZD1	246	Q9UP38
HQEGGFWHGFDISGH	FITM2	141	Q8N6M3
RGHGGFPVTNFWRHD	GCM1	126	Q9NP62
FWRGHAGGPHSNQHQ	DTNB	271	O60941
LHHGGNKGQRWLGYE	RALGDS	86	Q12967
GNWVQHHVSVGGLGD	MAN1C1	376	Q9NR34
SHGGSVLQDGWDHRG	LYG2	106	Q86SG7
WGQHHVSVGGLGDSF	MAN1A1	401	P33908
AHAGLGHIPWGTVFG	HEY1	171	Q9Y5J3
FKNVHGDIHAGLNGW	FBXO30	536	Q8TB52
FGQGAHHGLSEGWKE	SBSN	206	Q6UWP8
RFGQGVHHGLSEGWK	SBSN	331	Q6UWP8
SDSGGHHIGWGERQG	PHKA2	1051	P46019
QDGHSLLHWAALGGN	INVS	421	Q9Y283
GDFSQAGNKGHHVWV	MRPL46	241	Q9H2W6
WGRGSGNNGVGNIHS	TNRC6C	311	Q9HCJ0
GNNGVGNIHSGAWGH	TNRC6C	316	Q9HCJ0
AGAQHPYAQGWGLSH	RNF43	406	Q68DV7
VHGNSGAGNNWAKGH	TUBB1	91	Q9H4B7
FAGSGRHAAHWLGDN	SI	591	P14410
GGGHWSQVQTIHGTQ	ITGAL	441	P20701
GNEGQLGLCHHRGWK	SSC5D	91	A1L4H1
IQFHFHWGSLDGQGS	CA2	91	P00918
WQGHGLGGGEDCAHF	CLEC10A	271	Q8IUN9
WSNFFGHLPGHLNQG	ZNF451	896	Q9Y4E5
GHLPGHLNQGTFIWG	ZNF451	901	Q9Y4E5
QWGIVDLSGHQHLFG	ZNF865	146	P0CJ78
AGGRGHHRMGAVWQE	ZNF324	216	O75467
KSLHGWGHGSNGAGY	TIAM2	41	Q8IVF5
RGQTGHFEGSGHGSW	RNF10	151	Q8N5U6
YCHVRGGGELGLQWH	PREPL	506	Q4J6C6
IRHNAVAGGTHFGFW	PKHD1L1	2571	Q86WI1
NGGGHINHSIFWTNL	SOD2	91	P04179
GPGQSHARGGHWLAV	TJP3	511	O95049
AHGHGRGSWQFLFNG	ULBP1	131	Q9BZM6
GTGHGIGNFLCVHEW	XPNPEP2	521	O43895
GHNGLGKGFGDHIHW	TXNDC12	26	O95881
HNHSNSGGGWLSNSG	ZNF106	176	Q9H2Y7
WVAPRNRGSGFGHNG	YTHDF2	351	Q9Y5A9
RQGGWGSHAGPGNHV	TRERF1	81	Q96PN7
GGAWARRSHSVHGGL	LRFN4	601	Q6PJG9